Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in developing treatments for solid tumors due to its ability to cross cell membranes and bind selectively to target enzymes. Also investigated for anti-inflammatory applications owing to its structural similarity to bioactive quinoxaline derivatives. Commonly employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and reduced toxicity.